Skip to main content
NCBI home page
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1985 Apr;42(4):253–259. doi: 10.1136/oem.42.4.253

Relation of haemostatic function, neurovascular impairment, and vibration exposure in workers with different stages of vibration induced white finger.

M Bovenzi, C Giansante, A Fiorito, S Calabrese
PMCID: PMC1007465  PMID: 3978045

Abstract

Haemostatic function and neurovascular symptoms were investigated in 67 workers exposed to vibration and 46 comparable referents. Of these 65.6% of vibration workers complained of neurological disturbances (stages 0T, 0N of Taylor's classification for vibration induced white finger (VWF) and 20.9% suffered from Raynaud's phenomenon (stages 1-2-3). The severity of the staging symptoms showed a close relation with an index of vibration dose computed on the basis of vibration measurement and individual exposure time. Indices of platelet aggregation, both in vitro and in vivo, antithrombin III, fibrinogen and fibrinopeptide A levels were not different in the exposed workers compared with the referents. No relation was found between haemostatic parameters and the severity of VWF. Exposed workers responded to a cooling procedure with a more pronounced vasoconstriction in the digital vessels than the referents, as indicated by delayed recovery time of finger skin temperature after the cold test. These findings suggest that both in the early stages (0T, 0N) and in more severe stages of VWF (stages 1-2) cold induced hyperreactivity in the digital vessels and Raynaud's syndrome are vascular disorders of functional origin occurring without any prethrombotic alterations.

Full text

PDF
253

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azuma T., Ohhashi T., Sakaguchi M. Vibration-induced hyperresponsiveness of arterial smooth muscle to noradrenaline with special reference to Raynaud's phenomenon in vibration disease. Cardiovasc Res. 1978 Dec;12(12):758–764. doi: 10.1093/cvr/12.12.758. [DOI] [PubMed] [Google Scholar]
  2. BORN G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. doi: 10.1038/194927b0. [DOI] [PubMed] [Google Scholar]
  3. Blunt R. J., George A. J., Hurlow R. A., Strachan C. J., Stuart J. Hyperviscosity and thrombotic changes in idiopathic and secondary Raynaud's syndrome. Br J Haematol. 1980 Aug;45(4):651–658. doi: 10.1111/j.1365-2141.1980.tb07188.x. [DOI] [PubMed] [Google Scholar]
  4. Bovenzi M., Fiorito A., Giansante C., Calabrese S., Negro C. Platelet function and clotting parameters of vibration-exposed foundry workers. Scand J Work Environ Health. 1983 Aug;9(4):347–352. doi: 10.5271/sjweh.2402. [DOI] [PubMed] [Google Scholar]
  5. Brubaker R. L., Mackenzie C. J., Eng P. R., Bates D. V. Vibration white finger disease among tree fellers in British columbia. J Occup Med. 1983 May;25(5):403–408. [PubMed] [Google Scholar]
  6. Eche N., Boneu A., Sie P., Lucot H. Evacuated blood collection tubes and the determination of beta-thromboglobulin. Thromb Res. 1981 Aug 1;23(3):323–324. doi: 10.1016/0049-3848(81)90022-0. [DOI] [PubMed] [Google Scholar]
  7. FELDER D., RUSS E., MONTGOMERY H., HORWITZ O. Relationship in the toe of skin surface temperature to mean blood flow measured with a plethysmograph. Clin Sci. 1954 May;13(2):251–256. [PubMed] [Google Scholar]
  8. Ikehata K., Kawauchi S., Kohno F., Nishiyama M., Ide N. Increased platelet function and von Willebrand factor in vibration syndrome. Tokushima J Exp Med. 1980 Jun;27(1-2):23–28. [PubMed] [Google Scholar]
  9. Ludlam C. A., Moore S., Bolton A. E., Pepper D. S., Cash J. D. The release of a human platelet specific protein measured by a radioimmunoassay. Thromb Res. 1975 Jun;6(6):543–548. doi: 10.1016/0049-3848(75)90066-3. [DOI] [PubMed] [Google Scholar]
  10. Matoba T., Kusumoto H., Omura H., Kotorii T., Kuwahara H. Digital plethysmographic responses to auditory stimuli in patients with vibration disease. Tohoku J Exp Med. 1975 Apr;115(4):385–392. doi: 10.1620/tjem.115.385. [DOI] [PubMed] [Google Scholar]
  11. Miyashita K., Shiomi S., Itoh N., Kasamatsu T., Iwata H. Epidemiological study of vibration syndrome in response to total hand-tool operating time. Br J Ind Med. 1983 Feb;40(1):92–98. doi: 10.1136/oem.40.1.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Nerem R. M. Vibration-induced arterial shear stress: the relationship to Raynaud's phenomenon. Arch Environ Health. 1973 Mar;26(3):105–110. doi: 10.1080/00039896.1973.10666236. [DOI] [PubMed] [Google Scholar]
  13. Nossel H. L., Yudelman I., Canfield R. E., Butler V. P., Jr, Spanondis K., Wilner G. D., Qureshi G. D. Measurement of fibrinopeptide A in human blood. J Clin Invest. 1974 Jul;54(1):43–53. doi: 10.1172/JCI107749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Odegard O. R., Lie M., Abildgaard U. Heparin cofactor activity measured with an amidolytic method. Thromb Res. 1975 Apr;6(4):287–294. doi: 10.1016/0049-3848(75)90078-x. [DOI] [PubMed] [Google Scholar]
  15. Porter J. M., Bardana E. J., Jr, Baur G. M., Wesche D. H., Andrasch R. H., Rösch J. The clinical significance of Raynaud's syndrome. Surgery. 1976 Dec;80(6):756–764. [PubMed] [Google Scholar]
  16. Porter J. M., Snider R. L., Bardana E. J., Rösch J., Eidemiller L. R. The diagnosis and treatment of Raynaud's phenomenon. Surgery. 1975 Jan;77(1):11–23. [PubMed] [Google Scholar]
  17. SPAET T. H., CINTRON J. STUDIES ON PLATELET FACTOR-3 AVAILABILITY. Br J Haematol. 1965 May;11:269–275. doi: 10.1111/j.1365-2141.1965.tb06587.x. [DOI] [PubMed] [Google Scholar]
  18. Sroczyński J., Wegiel A., Pigoń-Wegiel A. Zachowanie sie układu krzepniecia u osób narazonych na hałas i wibracje. Med Pr. 1979;30(1):41–47. [PubMed] [Google Scholar]
  19. Zahavi J., Kakkar V. V. beta-Thromboglobulin--a specific marker of in-vivo platelet release reaction. Thromb Haemost. 1980 Aug 29;44(1):23–29. [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES